LEADER 01472nam  2200373z- 450 
001 9910689715203321
005 20161209102611.0
035   $a(CKB)5860000000032322
035   $a(BIP)008569972
035   $a(EXLCZ)995860000000032322
100   $a20220406c2002uuuu  -u-         -
101 0 $aeng
200 10$aReducing Americans' Vulnerability to Ecstasy Act of 2002 $ehearing before the Subcommittee on Crime, Terrorism, and Homeland Security of the Committee on the Judiciary, House of Representatives, One Hundred Seventh Congress, second session on H.R. 5519, October 10, 2002
210   $cWashington: U.S. G.P.O.
215   $a1 online resource (iii, 62 p.) $cill
311   $a0-16-069304-7 
517   $aReducing Americans' Vulnerability to Ecstasy Act of 2002 
606   $aEcstasy (Drug)$zUnited States
606   $aMethamphetamine abuse$zUnited States
606   $aDrug control$zUnited States
610   $aEcstasy (drug)
610   $aMethamphetamine abuse
610   $aDrug control
610   $aMedical
610   $aPsychology
610   $aPolitical science
615  0$aEcstasy (Drug)
615  0$aMethamphetamine abuse
615  0$aDrug control
712 02$aUnited States, Congress House Committee on the Judiciary Subcommittee on Crime, Terrorism, and Homeland Security Staff,$4oth
906   $aBOOK
912   $a9910689715203321
996   $aReducing Americans' Vulnerability to Ecstasy Act of 2002$93175684
997   $aUNINA